Research ArticleRheumatoid Arthritis

A Plasmablast Biomarker for Nonresponse to Antibody Therapy to CD20 in Rheumatoid Arthritis

See allHide authors and affiliations

Science Translational Medicine  21 Sep 2011:
Vol. 3, Issue 101, pp. 101ra92
DOI: 10.1126/scitranslmed.3002432

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article